To Study Effectiveness of Haritakyadi Kwath In Madhumeha.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2020/02/023137
- Lead Sponsor
- Hon Shri Annasaheb Dange Ayurvedic Medical College Ashta Sangli
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Willing to give consent to participate in the study.
2.Type of Disease-Apathyanimittaja Prameha (Diabetes Mellitus type2 NIDDM).
3.Fasting Blood sugar range- 126 to 250 mg/dl.
4.Post Prandial Blood sugar range-200 to 325 mg/dl
1.Patient not willing to participate in the study or not in position to give consent.
2.Patients of IDDM (Insulin Dependent Diabetes Mellitus)(DM Type 1).
3.Patients below 25 years of age & above 70 years of age.
4.Patients with Blood Sugar Level â?? FBS > 250 mg/dl PPBS > 325 mg/dl.
5.Patients with Gestational Diabetes.
6.Patients with severe complications (Chronic)[Micro & Macro-Vascular complications]
7.Patients in whom DM is caused due to Endocrinopathies like: -
a) Acromegaly
b) Cushingâ??s Syndrome
c)Glucagonoma
d)Pheochromocytoma
e)Hyperthyroidism.
8. Patients in whom DM is caused as a drug induced complications .
Ex:- a) Steroids
b) Thiazide like Diuretics
c) Nicotinic Acid
d) Protease Inhibitors
e) Beta Blockers
9.Patients suffering from any serious systemic disorders.
10.Patients with DKA (Diabetic Ketoacidosis), Lactic acidosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the efficacy of Haritakyadi Kwath in Madhumeha.Timepoint: Total Duration of treatment : 28Days. <br/ ><br>Follow up Assessment of trial drug during the course of treatment will be done on 0th- 7th-14th-21st -28th day of treatment. And after completion of treatment. <br/ ><br>
- Secondary Outcome Measures
Name Time Method To compare the efficacy of Haritakyadi Kwath with MetforminTimepoint: Total Duration of treatment : 28Days. <br/ ><br>Follow up Assessment of trial drug during the course of treatment will be done on 0th- 7th-14th-21st -28th day of treatment. And after completion of treatment. <br/ ><br>